Pharmacological interventions for acute pancreatitis: A network meta-analysis

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 11, 2014, Pages

  Gurusamy, Kurinchi Selvan ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; APROTININ; ASCORBIC ACID; GABEXATE MESILATE; LEXIPAFANT; NAFAMSTAT; OCTREOTIDE; PROBIOTIC AGENT; SELENIUM; SOMATOSTATIN; STEROID; TUMOR NECROSIS FACTOR ANTIBODY; ULINASTATIN;

ACUTE PANCREATITIS; DRUG EFFICACY; DRUG SAFETY; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; SYSTEMATIC REVIEW;

EID: 84963679338     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011384     Document Type: Review

References (37)

1. Ayub K, Slavin J, Imada R. Endoscopic retrograde cholangiopancreatography in gallstone-associated acute pancreatitis. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD003630.pub3].
2. Bang UC, Semb S, Nojgaard C, Bendtsen F. Pharmacological approach to acute pancreatitis. World Journal of Gastroenterology 2008;14(19):2968-76.
3. Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al.Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013;62(1):102-11.
4. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101(6):1644-55.
5. Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11-13, 1992. Archives of Surgery 1993;128(5):586-90.
6. Dias S, Welton NJ, Sutton AJ, Ades AE. NICE DSU Technical Support Document 1: Introduction to evidence synthesis for decision making, 2012. www.nicedsu.org.uk/TSD1%20Introduction.final.08.05.12.pdf (accessed 27 March 2014).
7. Dias S, Welton NJ, Sutton AJ, Caldwell DM, Lu G, Ades AE. NICE DSU Technical Support Document 4: Inconsistency in networks of evidence based on randomised controlled trials, 2012. www.nicedsu.org.uk/TSD4%20Inconsistency.final.08.05.12.pdf (accessed 27 March 2014).
8. Dias S, Sutton AJ, Welton NJ, Ades AE. NICE DSU Technical Support Document 3: Heterogeneity: subgroups, meta-regression, bias and bias-adjustment, 2012. www.nicedsu.org.uk/TSD3%20Heterogeneity.final%20report.08.05.12.pdf (accessed 27 March 2014).
9. Dias S, Welton NJ, Sutton AJ, Ades AE. NICE DSU technical support document 2: a generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials, 2013. www.nicedsu.org.uk/TSD2%20General%20meta%20analysis%20corrected%20Mar2013.pdf (accessed 27 March 2014).
10. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.) 1997;315(7109):629-34.
11. Elmunzer BJ, Scheiman JM, Lehman GA, Chak A, Mosler P, Higgins PD, et al.A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. The New England Journal of Medicine 2012;366(15):1414-22.
12. Center for Biologics Evaluation and Research, U.S. Food, Drug Administration. Guidance for industry adverse reactions section of labeling for human prescription drug and biological products - Content and format. www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm075057.pdf 2006 (accessed 4th July 2014).
13. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
14. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
15. Higgins JPT, Jackson D, Barrett JK, Lu G, Ades AE, White IR. Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies. Research Synthesis Methods 2012;3(2):98-110.
16. International Conference on Harmonisation of Technical Requiements for Registration of Pharmaceuticals for Human Use. Code of Federal Regulation & ICH Guidelines. Parexel Barnett, 1996.
17. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Statistics in Medicine 2004;23(20):3105-24.
18. Lu G, Ades AE, Sutton AJ, Cooper NJ, Briggs AH, Caldwell DM. Meta-analysis of mixed treatment comparisons at multiple follow-up times. Statistics in Medicine 2007;26(20):3681-99.
19. Medicines and Healthcare products Regulatory Agency (MHRA). Clinical trials for medicines: Safety reporting - SUSARs and DSURs. www.mhra.gov.uk/Howweregulate/Medicines/Licensingofmedicines/Clinicaltrials/Safetyreporting-SUSARsandASRs/ 2013 (accessed 4th July 2014).
20. Mills EJ, Ioannidis JP, Thorlund K, Schunemann HJ, Puhan MA, Guyatt GH. How to use an article reporting a multiple treatment comparison meta-analysis. JAMA 2012;308(12):1246-53.
21. NCBI. MeSH. NLM Controlled Vocabulary. Pancreas. www.ncbi.nlm.nih.gov/mesh/68010179 (accessed 4th July 2014).
22. Neumann I, Grassi B, Bdair F, Rada G. Antiproteases for acute pancreatitis. Cochrane Database of Systematic Reviews 2011, Issue 11. [DOI: 10.1002/14651858.CD009426].
23. Newell DJ. Intention-to-treat analysis: implications for quantitative and qualitative research. International Journal of Epidemiology 1992;21(5):837-41.
24. Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE, Bulsiewicz WJ, et al.Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 2012;143(5):1179-87.
25. Puhan MA, Guyatt GH, Murad MH, Li T, Salanti G, Caldwell D, et al.Selection of the best available evidence from an evidence network of treatment comparisons. An approach to rate the quality of direct, indirect and pooled evidence. gradepro.org/Rome2013/13aNMA.doc (accessed 12th August 2014).
26. Rada G, Neumann I, Roa M, Rojas L. Antioxidants for acute pancreatitis. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD009049].
27. Roberts SE, Akbari A, Thorne K, Atkinson M, Evans PA. The incidence of acute pancreatitis: impact of social deprivation, alcohol consumption, seasonal and demographic factors. Alimentary Pharmacology and Therapeutics 2013;38(5):539-48.
28. Sah RP, Dawra RK, Saluja AK. New insights into the pathogenesis of pancreatitis. Curremt Opinion in Gastroenterology 2013;29(5):523-30.
29. Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. Journal of Clinical Epidemiology 2011;64(2):163-71.
30. Schmid SW, Uhl W, Friess H, Malfertheiner P, Buchler MW. The role of infection in acute pancreatitis. Gut 1999;45(2):311-6.
31. Tenner S, Baillie J, DeWitt J, Vege SS, American College of Gastroenterology. American College of Gastroenterology guideline: management of acute pancreatitis. American Journal of Gastroenterology 2013;108(9):1400-15.
32. White IR, Barrett JK, Jackson D, Higgins JPT. Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression. Research Synthesis Methods 2012;3(2):111-25.
33. Imperial College and MRC. WinBUGS with DoodleBUGS. 1.4.3. London, UK: Imperial College and MRC, 2007.
34. Yadav D, Lowenfels AB. Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas 2006;33(4):323-30.
35. Yang AL, Vadhavkar S, Singh G, Omary MB. Epidemiology of alcohol-related liver and pancreatic disease in the United States. Archives of Internal Medicine 2008;168(6):649-56.
36. Yang X, Zeng X, Wu T. Lexipafant for acute pancreatitis. Cochrane Database of Systematic Reviews 2011, Issue 9. [DOI: 10.1002/14651858.CD009309].
37. Zhang Y, Chen QB, Gao ZY, Xie WF. Meta-analysis: octreotide prevents post-ERCP pancreatitis, but only at sufficient doses. Alimentary Pharmacology & Therapeutics 2009;29(11):1155-64.